Fatty Liver Disease*
Bpogen effective at preventing and reducing the lipid accumulation in the liver by Hepatitis Research Center in National Taiwan University Hospital.
Fatty liver refers to liver damage caused by the accumulation of a large amount of fat in liver cells. The vast majority of patients do not have obvious symptoms, so they do not actively control long-term liver function abnormalities.
Febico uniquely cultivated spirulina contains high levels of zinc, selenium, chromium and other antioxidants which are vital and beneficial for liver care. Research studies have shown continue use of Bpogen at early stage can help normalization of cholesterol, fat in liver and chemicals inducing liver inflammation condition.
Liver lipid level
Taking Bpogen for 6 weeks can reduce amount of liver lipid level, animal study done by National Taiwan University Hospital, blue color is cell nucleus stained by Hoechst, red color is lipid stained by Oil Red O.
Improve functions of liver
Taking Drug and Bpogen combined is better than drug only and can improve and maintain the functions of liver.
Reduce Fibrosis Condition
Taking Bpogen can effectively reduce liver fibrosis. Additionally, taking higher doses of Bpogen will enhance the degree of improvement in liver surface fibrosis.
Improve liver regeneration after liver damage
Taking Bpogen can increase the survival rate after liver resection surgery and enhance the proportion of liver regeneration."
Liver cells damages (AST&ALT)
Liver cells damages (AST&ALT) decrease indicates restore of liver function by Human Clinical trials conducted at Kuang-Tien General Hospital.
Hepatitis B rapid clearance of viral titer and restore of liver function
Bpogen can facilitate the reduction in virus titer and 60% patients develop HBbAg (+), i.e. cure of hepatitis B, study on Human Clinical trials conducted at Kuang-Tien General Hospital.
Hepatitus B remove heavy metals
Taking Drug and Bpogen combined can facilitate the removal of heavy metals (Cu, Fe, Al) in Hepatitis B patients, study on Human Clinical trials conducted at Kuang-Tien General Hospital.
- Kai-Wen Huang, M.D, Attending physician and assistant professor of Department of Surgery and Hepatitis Research Center in National Taiwan University Hospital
- Wang-Sheng Ko, M.D.., Kuang-Tien General Hospital, Tai-Chung.
- *These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
- Related Product